Biosimilar Red Tape Elimination Act

Congress targets insulin costs and drug patent abuses

Congress is advancing legislation aimed at reducing prescription drug costs and reforming patent practices. The INSULIN Act, which has passed a key Senate committee, proposes capping out-of-pocket insulin costs at $35 p…